Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

bluebird bio, Inc. - Common Stock (NQ:BLUE)

4.970 UNCHANGED
Last Price Updated: 4:00 PM EDT, May 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about bluebird bio, Inc. - Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
22 23 Next >
News headline image
Recap: bluebird bio Q3 Earnings ↗
bluebird bio (NASDAQ:BLUE) reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
bluebird bio Reports Third Quarter 2022 Financial Results and Highlights Operational Progress
From bluebird bio, Inc.
Via Business Wire
News headline image
bluebird bio to Present at the 31st Annual Credit Suisse Healthcare Conference
From bluebird bio, Inc.
Via Business Wire
News headline image
Better Buy: CRISPR Therapeutics vs. Bluebird Bio ↗
These two companies have performed almost equally poorly on the stock market in the past year. 
Via The Motley Fool
News headline image
What's Next For Cell Therapy In Oncology? Enlivex (NASDAQ: ENLV) Says It Has The Answers ↗
Since Robert Hooke discovered cells in 1665 and Theodor Schwann proposed the classical cell theory in 1839, the cell therapy industry has grown by leaps and bounds. 
Via Benzinga
News headline image
Short Volatility Alert: bluebird bio, Inc. ↗
On Wednesday, shares of bluebird bio, Inc. (NASDAQ: BLUE) experienced volatile short activity. After the activity, the stock price went down -10.06% to $6.17. The overall sentiment for BLUE has been... 
Via Benzinga
News headline image
What 5 Analyst Ratings Have To Say About bluebird bio ↗
Analysts have provided the following ratings for bluebird bio (NASDAQ:BLUE) within the last quarter: 
Via Benzinga
News headline image
Why Legend Biotech's Shares Jumped 14.2% On Tuesday ↗
The company presented news regarding early revenue figures for a multiple myeloma therapy it collaborated on. 
Via The Motley Fool
News headline image
Biotech Stocks Well-Positioned For The Fourth Quarter ↗
The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far. 
Via Talk Markets
News headline image
Real Endpoints Marketplace announces collaboration with bluebird bio to help scale delivery of a first-of-its-kind value-based contract for one-time gene therapy
The risk-sharing agreement removes economic uncertainties, enabling regional and mid-sized health plans to provide patients with transfusion-dependent beta-thalassemia access to ZYNTEGLO 
From Real Endpoints
Via GlobeNewswire
News headline image
Bluebird Bio Offers World's Most Expensive Drugs, But Uncertainty Looms Over Its Financial Future ↗
Bluebird Bio Inc (NASDAQ: BLUE) is about to become the seller of the two most expensive drugs in the U.S. and probably the world. The price tag of $3 million is already facing backlash. 
Via Benzinga
News headline image
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday ↗
Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37. 
Via Benzinga
News headline image
AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know ↗
Most FDA decisions scheduled for September yielded positive results, but there were stray disappointments as well. Seven new molecular entities, or NMEs, were approved during the month, taking the... 
Via Benzinga
News headline image
Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
US Stock Futures Mixed After Recording Losses Last Week; Fed Speakers In Focus ↗
Pre-open movers 
Via Benzinga
News headline image
Amazon, bluebird bio And 3 Stocks To Watch Heading Into Monday ↗
With US stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
News headline image
Stitch Fix, Tellurian And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗
U.S. stock futures traded slightly higher this morning after recording losses in the previous session. Here are some big stocks moving lower in today’s pre-market trading session. 
Via Benzinga
News headline image
Why ECMOHO Is Trading Lower By 29%; Here Are 28 Stocks Moving Premarket ↗
Gainers Ampio Pharmaceuticals, Inc. (NYSE: AMPE) rose 17.8% to $0.0942 in pre-market trading after declining around 5% on Tuesday. 
Via Benzinga
News headline image
Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
  
Via Benzinga
News headline image
Why Virios Therapeutics Is Trading Lower By 75%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 51% to $0.4957. Crown ElectroKinetics, last month, posted a Q4 net loss of $4.5 million. 
Via Benzinga
News headline image
Cognex, Oxford Industries And Some Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
NIKE Price Target Cut By This Analyst; Also Benchmark Sees $325 For Danaher ↗
Barclays cut the price target on NIKE, Inc. (NYSE: NKE) from $125 to $110. Barclays analyst Adrienne Yih also downgraded the stock from Overweight to Equal-Weight. NIKE shares fell 4.3% to trade at... 
Via Benzinga
News headline image
Nikola, Super Micro Computer And Other Big Losers From Monday ↗
U.S. stocks closed higher with the Dow Jones gaining around 197 points on Monday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
News headline image
What's Going On With Bluebird Bio Stock Today? ↗
Bluebird Bio Inc (NASDAQ: BLUE) shares are trading lower Monday. The stock initially surged in premarket trading following the U.S. Food and Drug Administration's accelerated approval of SKYSONA, but... 
Via Benzinga
News headline image
AutoZone (AZO) Stock Pops as Sales Beat Expectations ↗
AutoZone (AZO) stock is rising on Monday following the release of the automotive part company's earnings report for fiscal Q4 2022. 
Via InvestorPlace
News headline image
Bluebird Bio (BLUE) Stock Is in Focus Following FDA Approval ↗
The Boston-based biotech company has secured FDA approval for one of its gene therapies. Let's take a closer look at BLUE stock. 
Via InvestorPlace
News headline image
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday ↗
Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday. 
Via Benzinga
News headline image
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session ↗
Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74. 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.